Alpine Global Management’s Cantel Medical Corporation CMD Stock Holding History

Alpine Global Management’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-4,914	Closed	-$348K	–	522
2019 Q4	$348K	Buy	+4,914	New	+$356K	0.07%	244
2017 Q3	–	Sell	-4,843	Closed	-$377K	–	253
2017 Q2	$377K	Buy	+4,843	New	+$364K	0.12%	73

Other funds holding CMD

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Diker Management New York $112M AUM 59.78% 1-Year Est. Return

Alpine Global Management's CMD Position: Q1 2020 in Review

Alpine Global Management sold out of Cantel Medical Corporation (CMD) in Q1 2020, closing a stake of 4,914 shares — an estimated $348K sold.

Alpine Global Management first reported a position in CMD in Q2 2017 and held it in 2 quarters. The position peaked at $377K in Q2 2017. 213 funds tracked by Wall St. Rank hold CMD as of Q1 2020.

Alpine Global Management reported no remaining Cantel Medical Corporation position as of Q1 2020 after selling out during the quarter.
Alpine Global Management sold 4,914 Cantel Medical Corporation shares in Q1 2020, an estimated $348K.
Alpine Global Management first reported a position in Cantel Medical Corporation in Q2 2017 and held it in 2 quarters.
Alpine Global Management's Cantel Medical Corporation position peaked at $377K in Q2 2017.
213 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2020.

Based on Alpine Global Management's 13F filing for Q1 2020, filed 9 Apr 2020.